Skip to main content
Top
Published in: Journal of Endocrinological Investigation 5/2021

Open Access 01-05-2021 | Bariatric Surgery | Original Article

What predicts the unsuccess of bariatric surgery? An observational retrospective study

Authors: C. D’Eusebio, S. Boschetti, F. Rahimi, G. Fanni, A. De Francesco, M. Toppino, M. Morino, E. Ghigo, S. Bo

Published in: Journal of Endocrinological Investigation | Issue 5/2021

Login to get access

Abstract

Purpose

Bariatric surgery (BS) has been recognized as an effective treatment for most patients with morbid obesity, but a variable range of patients failed to achieve a successful weight-loss. Controversial data are available about predictors of unsuccess. We aimed to retrospectively assess whether clinical baseline characteristics of patients submitted to sleeve gastrectomy (SL) or gastric bypass (GBP) were associated with unsuccessful weight-loss after 12 and 24-month follow-up.

Methods

Three hundred patients who underwent BS from the 1st January 2016, with at least 24-months follow-up, were enrolled. Patients were divided according to their percentage of excess weight-loss (%EWL) either < 50% or ≥ 50% after 12 and 24-month follow-up.

Results

None of the patients was lost at follow-up; 56 (18.7%) patients showed a %EWL < 50% at 24 months. Age, neck circumference, obstructive sleep apnea (OSA) were significantly higher, while total cholesterol and %EWL 6-months lower in those with %EWL < 50% at 12-months. Age, neck circumference, male and OSA rates were increased, while %EWL at 6-months lower in patients with %EWL < 50% at 24-months. In a multiple regression model, age (OR = 1.076; 95% CI 1.029–1.125; p = 0.001; OR = 1.066; 1.027–1.107; p < 0.001) and %EWL at 6-months (OR = 0.876; 0.840–0.913; p < 0.001; OR = 0.950; 0.928–0.972; p < 0.001) were associated with %EWL < 50% both at 12- and 24-months, respectively, and neck circumference (OR = 1.142; 1.011–1.289; p = 0.032) with %EWL < 50% at 24-months.

Conclusion

Older age, larger neck circumference, and %EWL at 6-months were significantly associated with BS unsuccess, showing almost 90% of those patients an unsuccessful weight-loss early after surgery. Further larger studies with longer follow-up are needed to confirm these results.
Literature
1.
8.
go back to reference O'Brien PE, Hindle A, Brennan L, Skinner S, Burton P, Smith A, Crosthwaite G, Brown W (2019) Long-term outcomes after bariatric surgery: a systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single-centre review of 20-year outcomes after adjustable gastric banding. Obes Surg 29:3–14. https://doi.org/10.1007/s11695-018-3525-0CrossRefPubMed O'Brien PE, Hindle A, Brennan L, Skinner S, Burton P, Smith A, Crosthwaite G, Brown W (2019) Long-term outcomes after bariatric surgery: a systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single-centre review of 20-year outcomes after adjustable gastric banding. Obes Surg 29:3–14. https://​doi.​org/​10.​1007/​s11695-018-3525-0CrossRefPubMed
37.
Metadata
Title
What predicts the unsuccess of bariatric surgery? An observational retrospective study
Authors
C. D’Eusebio
S. Boschetti
F. Rahimi
G. Fanni
A. De Francesco
M. Toppino
M. Morino
E. Ghigo
S. Bo
Publication date
01-05-2021
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 5/2021
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-020-01398-z

Other articles of this Issue 5/2021

Journal of Endocrinological Investigation 5/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine